Riot Platforms: A $311M AMD Deal Changes the HPC Game America's Weight-Loss Fixation Is Driving Massive Growth Industry consultancy firm Grand View Research forecasts the GLP-1 drug market to grow by a compound annual growth rate of 18.54% between 2024 and 2030, resulting in a global market value increase from $13.84 to $48.84 billion
A group of advisers to the Food and Drug Administration voted in favor of allowing pharmacies to compound peptides like BPC-157 and TB-500, which means the hot-button peptides may soon become more broadly available to Americans
Works With or Without Other Apps Already tracking food or weight elsewhere
Pinching a fold of skin and inserting the needle at a 45-degree angle ensures proper placement
Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
Retatrutide is an investigational drug that is not approved by the FDA or any regulatory body for the treatment of obesity, diabetes, or body recomposition outside of clinical trials
